<DOC>
	<DOC>NCT00714090</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy of add-on therapy with repetitive Transcranial Magnetic Stimulation (rTMS) and venlafaxine in the treatment of major depressive disorders compared to venlafaxine only (the optimal medication) and to rTMS only.</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression</brief_title>
	<detailed_description>rTMS parameters : Intensity of 120% of individually determined motor threshold; frequency : 1 Hz; 360 impulsions; on period : 1 min; off period : 30 s.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Adults Clinical diagnosis of major depressive disorder (DSMIV) HDRS17 items &gt; 20 Failure of one antidepressant treatment (efficacious doses for 6 weeks at least) I or II bipolar disorder Psychotic features Failure of one previous venlafaxine treatment Addiction comorbidity or schizophrenia comorbidity Involuntary hospitalization Seizures history Pregnancy or breastfeeding Somatic comorbidity able to impact on cognitive functions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>repetitive Transcranial Magnetic Stimulation (rTMS)</keyword>
	<keyword>Major depressive disorders</keyword>
	<keyword>Depression</keyword>
	<keyword>Venlafaxine</keyword>
</DOC>